drug discovery

How assays are set up and validated based on guidelines

Laboratory assays set up for Pre-Clinical and Clinical Trials must fulfill strict criteria in every aspect of the assessment including the Protocol,.

read more

Neurotoxicity Assay Using Alternative Models

A wide variety of substances like chemicals, pollutants, or drugs can damage the nervous system, causing neurotoxicity and leading to neurological.

read more

Dose Range Finding Studies in Preclinical Research

Before any drug can be given to a human subject its safety and efficacy must be assessed. The Dose Range Finding (DRF) assay is an important test in.

read more

Alternative Animal Models for Neurogenerative Diseases

Neurodegenerative diseases (NDs) are disorders caused by de progressive and irreversible destruction of the nervous tissue that produces memory and.

read more

Endocrine Disrupting Studies in Zebrafish

Exposure to harmful chemicals surrounds us in our daily lives. From the water-plastic bottles consume to the non-stick pans we use to cook, the toys.

read more

The Health and Environmental Sciences Institute’s (HESI) efforts towards global health and more sustainable science

The HESI (Health and Environmental Sciences Institute) is an independent non-profit organization that is based in Washington in the United States.

read more

Hepatotoxicity Assay in Drug Discovery

As the liver is the most important organ in Drug metabolism, one of the major causes of drug attrition in the process of Drug discovery is Drug.

read more

Which are the main European Regulatory Agencies?

The control and regulation of the safe and proper use of chemical compounds, medicines, and physical agents present in the industry, food, and.

read more

What toxicity types are there?

Toxicity tests are carried out to determine the toxicity level a chemical has to live organisms. To measure the toxicity level of a chemical, these.

read more

European and US agencies Leading to Promote New Alternative Methods in Research

The Food and Drug Administration (FDA) is pushing for alternative models in drug development is a positive step forward for both patients and the.

read more